Little study has been made of the effect of sulfanilamide and its derivatives on infections due to the bacillus of swine erysipelas (erysipeloid). The only report that has come to our attention is that of Schoch and Shelmire,1 in 1940, who stated the belief that sulfanilamide therapy was of some value in the treatment of erysipeloid on the basis of the success attained in 3 of 4 patients treated. In the fourth patient, as the infection continued to extend after six days of chemotherapy, the drug was regarded as being ineffective. Because of the variable course of erysipeloid, as Klauder2 has emphasized, the evaluation of treatment is somewhat difficult. However, because of the rapid response to treatment with sulfathiazole (2-sulfanilamidothiazole) and the relative rarity of erysipeloid, we are prompted to report the results obtained with this compound used to the exclusion of other measures in the treatment of
Kulchar GV, Rosenberg E. SULFATHIAZOLE IN THE TREATMENT OF ERYSIPELOID. Arch Derm Syphilol. 1941;43(5):846–847. doi:10.1001/archderm.1941.01490230086013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: